 |
Advanced Hydrocolloids |
|
Utilising our
Potentiated Electrolysis manufacturing technology as well as
some other specific ingenuities, we are capable
of producing Advanced Hydrocolloid products. Thus far we have developed a highly potentiated colloidal silver based range of products. The advanced colloidal silver based product range utilises our Potentiated Electrolysis manufacturing technology combined with the addition of a stabiliser into the brewing process (for more effective and efficient brewing) as well as other active ingredients into the brewed colloid itself (for increased overall antimicrobial, antiviral and general therapeutic effects). General OverviewColloidal silver has a long and well established reputation for being able to safely kill many different types of harmful microbes and viruses. In fact, until some flawed product concepts were linked to various health problems, colloidal silver was even very commonly used in most all hospitals. With lessons learned and plenty of time for the public to forget about these past incidences, more and more silver based products are now coming onto the market each and every year due to an ever increasing consumer awareness of the capabilities of colloidal silver products. However, there are unfortunately still a number of commercial viability issues that make the end products far too expensive and/or far too ineffective. And, as such, these issues are substantially inhibiting both the diversification and the growth of the marketplace. One of the biggest drawbacks of current products is that the production methods used are not generally capable of producing a product that is both highly concentrated and highly effective. As such, most all products currently on the market are low strength and therefore require a substantial amount to be used in order to be highly effective. What's more, being of low strength also makes the products highly unsuitable for topical applications and other similar highly isolated applications. Another major issue is that most current mass production methods take around 16 hours or more to produce 1 relatively small batch of colloidal silver, thus requiring a quite numerous amount of very expensive manufacturing equipment in order to be able to produce in very high volumes. Another major drawback is that the products are very heavy and bulky, thus making them very expensive to package and distribute as well as making them very expensive to purchase at the consumer level. Although there are a number of products on the market that attempt to address one or more of the aforementioned issues, and thus provide a cheap, effective and compact product range, few have actually been very successful. This has been mainly due to their methods resulting in problems with decreased effectiveness and/or increased risks of adverse effects. After much research and development we have discovered a novel production method that:
Product ConceptsWe can supply the end product directly as a pure liquid product to both consumers and other product manufacturers or use it to produce many other types of products in-house, such as:
We have also developed a method of making many of our products (especially our creams, lotions and liquid gel products) approximately 6 to 8 times even more concentrated. Essentially, what this means is that we can concentrate the silver content of 1 litre of regular colloidal silver into a product that is around just 150 millilitres. As such, these products can be made even more lightweight and potent, thus making them even more cheaper to package and distribute as well as being cheaper in price for consumers yet overall much more highly effective (especially for topical and surface applications). Many of these products can also be combined with other relevant active ingredients and technologies so as to not only give specific antimicrobial and antiviral effects for specific product concepts but, where applicable, to also give greater overall effects in general. It is our belief that our products will help to not only serve the growing concerns of resistant microbes but to also serve as a solution for unmet needs such as food poisoning and gastroenteritis. For information regarding the development pipeline of this technology, please click here. |
|
| .......................................... | |
| Members Area | |
| Retrieve Password | |
| Menu | |
 |
Introduction |
|
|
Our Newly Discovered Metabolic Networks |
|
|
Our Metabolic Amplification Platform Technology |
|
|
Nutraceutical Applications |
|
|
Pharmaceutical Applications |
|
|
Phytoceutical Applications |
|
|
Zooceutical Applications |
|
|
R & D Applications |
|
|
Diagnostic Applications |
|
|
Our Medical Treatments |
|
|
Advanced Hydrocolloids |
|
|
Partnering With Us |
|
|
Technology Pipeline |